Solid Tumors Archives - IPN Delhi India

abaloparatide injection

abaloparatide injection
for subcutaneous use Initial U.S. Approval: 2017

As specified in the prescribing information, abaloparatide injection is indicated for the treatment of osteoporosis. TYMLOS is a human parathyroid hormone related peptide [PTHrP(1-34)] analog indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture.

Facts about abaloparatide injection

Approval Date: 2017
Proprietary Name: TYMLOS (abaloparatide) injection
Active Ingredient(s): abaloparatide
FDA-approved use: osteoporosis
Dosage Form: Injection: 3120 mcg/1.56 mL (2000 mcg/mL) in a single-patient-use prefilled pen. The prefilled pen delivers 30 daily doses of 80 mcg abaloparatide in 40 mcL of sterile, clear, colorless solution
Medicine Approved By: US FDA
Manufacturer: Radius Health, Inc.
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “abaloparatide injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

abemaciclib tablets

Breast Cancer

abemaciclib tablets,
for oral use Initial U.S. Approval: 2017

Verzenio (abemaciclib) is a medication indicated for the treatment of women with HR-positive, HER2-negative advanced or metastatic breast cancer.

Facts about abemaciclib tablets

Disease Indications-Breast Cancer
Manufacturer-Lilly
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “abemaciclib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

abiraterone acetate tablets

Prostate

abiraterone acetate tablets
For Oral Administration Initial U.S. Approval – 2011

abiraterone acetate tablets is a CYP17 inhibitor indicated for use in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.

Facts about abiraterone acetate tablets

Approval Date: 2011
Proprietary Name: On Request
Active Ingredient(s): abiraterone acetate tablets
Dosage Forms And Strengths: Tablet 250 mg
Company: Centocor Ortho Biotech Inc.
Current indications: prostate cancer
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import abiraterone acetate tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

abrocitinib tablets

Skin

abrocitinib tablets
for oral use Initial U.S. Approval: 2022

CIBINQO is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable.

Facts about abrocitinib tablets

Approval Date: 1/14/2022
Proprietary Name: Cibinqo
Active Ingredient(s): abrocitinib
FDA-approved use: To treat refractory, moderate-tosevere atopic dermatitis
Dosage Form: Tablet
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “abrocitinib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

acalabrutinib capsules

Lymphoma

acalabrutinib capsules
for oral use Initial U.S. Approval: 2017

Calquence (acalabrutinib) is a medication used for the treatment of Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukaemia (CLL) and Small Lymphocytic Leukaemia (SLL).

Facts about acalabrutinib capsules

Disease Indications-Lymphoma
Manufacturer-AstraZeneca Pharmaceuticals LP
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “acalabrutinib capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Adagrasib Tablets

Lung

Adagrasib Tablets, for oral use Initial U.S. Approval: 2022

Generic Name – Adagrasib
Medicine Type – Tablets / Oral
Manufacturer Name – Mirati
Approval Year – 2022
Approved by – Food and Drug Administration

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import adagrasib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

ado-trastuzumab emtansine for injection

Breast Cancer

ado-trastuzumab emtansine for injection,
for intravenous use Initial U.S. Approval: {YYYY}

Kadcyla (trastuzumab emtansine) is a cancer medicine that is used to treat advanced or metastatic HER2-positive breast cancer (cancer that has spread to other parts of the body) in adults who previously received trastuzumab and a taxane.

Facts about ado-trastuzumab emtansine for injection

Disease Indications-Breast Cancer
Manufacturer-Genentech, Inc
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ado-trastuzumab emtansine for injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

afatinib tablets

Lung

afatinib tablets
for oral use Initial U.S. Approval: 2013

afatinib tablets is a kinase inhibitor indicated for: • First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test.

Facts about afatinib tablets

Approval Date: 2013
Proprietary Name: On Request
Active Ingredient(s): afatinib tablets
Dosage Forms And Strengths: Tablets: 40 mg, 30 mg, and 20 mg
Company: Boehringer Ingelheim Pharmaceuticals, Inc.
Current indications: metastatic non-small cell lung cancer (NSCLC)
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import afatinib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

alectinib capsules

Lung

alectinib capsules,
for oral use Initial U.S. Approval: 2015

Alectinib is prescribed for the treatment of a certain type (anaplastic lymphoma kinase (ALK)-positive) of non-small cell lung cancer that has spread to other parts of the body. It belongs to a group of medicines known as kinase Inhibitors given for patients who cannot take another drug, crizotinib, or in those in whom crizotinib was ineffective.

Facts about alectinib capsules

Disease Indications-Lung Cancer
Manufacturer-Roche Registration GmbH
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import alectinib capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

ALIQOPA (copanlisib) for Injection

Lymphoma

ALIQOPA (copanlisib) for injection, for intravenous use Initial U.S. Approval: 2017

ALIQOPA is a kinase inhibitor indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies.

Copanlisib is Generic Name for the trade name drug Aliqopa®. Aliqopa® is manufactured by Bayer HealthCare Pharmaceuticals Inc. Aliqopa® is approved by the FDA. Date of approval: September 14, 2017. Aliqopa® is supplied for injection: 60 mg as a lyophilized solid in single-dose vial for reconstitution for intravenous administration.

Medicine Name: Aliqopa
Generic Name: Copanlisib
Dosage Form & Strength: For injection: 60 mg as a lyophilized solid in single-dose vial
Manufactured By: Bayer Corporation

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import ALIQOPA (copanlisib) for Injection ” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

List of Oncology Medication For

Solid Tumors

Indian Pharma Network

M: +9891296838 / 9811747774E: med@indianpharmanetwork.co.in

abaloparatide injection for subcutaneous use Initial U.S. Approval: 2017

Facts about abaloparatide injection

Access the best support services globally

abemaciclib tablets, for oral use Initial U.S. Approval: 2017

Facts about abemaciclib tablets

Access the best support services globally

abiraterone acetate tablets For Oral Administration Initial U.S. Approval – 2011

Facts about abiraterone acetate tablets

Access the best support services globally

abrocitinib tablets for oral use Initial U.S. Approval: 2022

Facts about abrocitinib tablets

Access the best support services globally

acalabrutinib capsules for oral use Initial U.S. Approval: 2017

Facts about acalabrutinib capsules

Access the best support services globally

Adagrasib Tablets, for oral use Initial U.S. Approval: 2022

Access the best support services globally

ado-trastuzumab emtansine for injection, for intravenous use Initial U.S. Approval: {YYYY}

Facts about ado-trastuzumab emtansine for injection

Access the best support services globally

afatinib tablets for oral use Initial U.S. Approval: 2013

Facts about afatinib tablets

Access the best support services globally

alectinib capsules, for oral use Initial U.S. Approval: 2015

Facts about alectinib capsules

Access the best support services globally

ALIQOPA (copanlisib) for injection, for intravenous use Initial U.S. Approval: 2017

Access Patient Name Basis Treatment

Contact Info

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

M: +9891296838 / 9811747774
E: med@indianpharmanetwork.co.in

abaloparatide injection
for subcutaneous use Initial U.S. Approval: 2017

abemaciclib tablets,
for oral use Initial U.S. Approval: 2017

abiraterone acetate tablets
For Oral Administration Initial U.S. Approval – 2011

abrocitinib tablets
for oral use Initial U.S. Approval: 2022

acalabrutinib capsules
for oral use Initial U.S. Approval: 2017

ado-trastuzumab emtansine for injection,
for intravenous use Initial U.S. Approval: {YYYY}

afatinib tablets
for oral use Initial U.S. Approval: 2013

alectinib capsules,
for oral use Initial U.S. Approval: 2015